West Pharmaceutical Services Declares $0.22 Dividend, Launches $1 Billion Buyback
West Pharmaceutical Services declared a quarterly dividend of $0.22 per share, payable May 6 to shareholders of record April 29. The company authorized a new $1 billion share repurchase program with no expiration following full utilization of its prior buyback.
1. Quarterly Dividend Details
On February 16, 2026, West Pharmaceutical Services’ Board of Directors declared a regular quarterly dividend of $0.22 per share on common stock, payable May 6, 2026 to shareholders of record on April 29, 2026.
2. New $1 Billion Share Repurchase Program
On February 17, 2026, the board authorized a new share repurchase program authorizing up to $1 billion in open‐market or negotiated purchases with no expiration date; repurchase timing will depend on stock price, market conditions and regulatory requirements.
3. Strategic Implications
The previous repurchase program was fully utilized by December 31, 2025, and the fresh $1 billion authorization underscores management’s commitment to capital return and potential support for share value through flexible buybacks.